Neues NASH-IPO ein Investment wert?
Seite 2 von 2 Neuester Beitrag: 16.12.24 21:40 | ||||
Eröffnet am: | 15.02.21 07:27 | von: Ice-Nine com. | Anzahl Beiträge: | 41 |
Neuester Beitrag: | 16.12.24 21:40 | von: Balu4u | Leser gesamt: | 13.819 |
Forum: | Börse | Leser heute: | 8 | |
Bewertet mit: | ||||
Seite: < 1 | > |
https://seekingalpha.com/news/...eed_news_all&utm_medium=referral
https://www.finanznachrichten.de/...ien/terns-pharmaceuticals-inc.htm
schwache TERN-201 (VAP-1 inhibitor) Phase 1 Daten
"While treatment with TERN-201 10 mg resulted in near complete (>98%) inhibition of plasma VAP-1 in most subjects, there were no meaningful changes in exploratory serum or imaging NASH biomarkers with TERN-201 10 mg relative to placebo"
https://ir.ternspharma.com/news-releases/...se-1-aviation-trial-vap-1
65 Mio. $ Offering
- 12,25 Mio. neue Aktien zu je 2,41$ = 29,6 Mio. $
- 14,63 Mio. Warrants zu je 2,4199$ = 35,4 Mio. $
https://ir.ternspharma.com/news-releases/...n-oversubscribed-offering
https://de.investing.com/news/company-news/...ntenstudie-93CH-2798396